Genetic engineering of Mycobacterium leprae to Glow and Grow
Genetic engineering of Mycobacterium leprae to Glow and Grow
批准号:
10526890
负责人:
WILLIAM Robert JACOBS
金额:
$25.2万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-05-20 至 2024-04-30
关键词:
ATP-Binding Cassette TransportersAchievementAcid Fast Bacillae Staining MethodAnabolismAnimal ModelBacillusBacteriaBacteriophagesBioluminescenceCarbonCell WallCellsCommunitiesComplementConsumptionCosmidsDNADNA SequenceDataDetectionDeveloping CountriesDevelopmentDiagnosisDiseaseElectroporationEnergy TransferEngineeringEnzymesEvolutionFamily DasypodidaeFatty AcidsFirefliesGenerationsGenesGeneticGenetic EngineeringGenomeGenomicsGlucoseGoalsGreen Fluorescent ProteinsGrowthHarvestHomologous GeneHomoserineHumanImmunologicsIn VitroInfectionIntravenousIronLeadLeprosyLibrariesLightLipidsLuciferasesMetabolicMethionineMethodsModelingMusMycobacterium lepraeMycobacterium tuberculosisNADHNude MiceOrganOrganismOxidoreductasePantothenic AcidPathway interactionsPersonsPharmaceutical PreparationsPharmacotherapyPlasmidsPredispositionProcessProteinsPseudogenesRadioactivityRecording of previous eventsRegimenRegulatory PathwayReporterReportingResearchResearch PersonnelResearch TechnicsSiderophoresSignal TransductionSourceStainsStigmatizationSystemTechniquesTestingTherapeutic AgentsTimeTissue imagingTissuesWorkacid fast bacteriabasecostdrug developmentdrug efficacydrug testingfoothuman diseaseimprovedin vivo imaging systemintracellular parasitismmycobacterialmycobactinsnanoluciferasenovelnovel therapeuticsoxidationpathogenpromotertooluptakevaccine development
中文摘要
项目总结/摘要
麻风病在整个人类历史上一直困扰着人类,
发展中国家虽然麻风杆菌是第一个被报道的细菌,
与人类疾病有关,但从未在人工培养基上培养过。可以
生长在裸鼠的足垫中或系统地生长在九带犰狳中。持一代
在14天的时间内,通过计数抗酸杆菌来进行测试药物方案,
费力且耗时。比较了M.麻风杆菌DNA序列与M.
结核病提示不能培养M.人工培养基上的麻风病可能是由
不能合成蛋氨酸、泛酸和分枝杆菌素。利用遗传学工具,
为M.结核病,我们假设M。麻风可以稳定地转化噬菌体,
基于整合精通质粒。我们计划将生物发光共振
能量转移(BRET)-Nanoluc和近红外蛋白进入质粒进行检测
转化体此外,我们假设M.麻风病人与失踪
蛋氨酸和泛酸生物合成基因和分枝杆菌素转运蛋白将使M.
麻风病在人造培养基上生长个核磁会发光麻风菌株
发展和评估控制M的免疫机制的能力。麻风
感染.利用基因工程技术对M.在人造培养基上生长,
理解导致专性细胞内寄生的进化过程。
英文摘要
Project Summary/ Abstract
Leprosy has plagued mankind throughout human history and still afflicts 2 to 3 million people in
Developing Countries. Although the leprosy bacillus was the first bacterium reported to be
associated with human disease, it has yet never been cultivated on artificial media. It can be
grown in the footpads of nude mice or systemically in nine-banded armadillos. With a generation
time of 14 days, testing drug regimens are performed by counting acid-fast bacilli which is
laborious and time-consuming. The comparison of the M. leprae DNA sequence to M.
tuberculosis suggests the inability to culture M. leprae on artificial media might result from the
inability to synthesize methionine, pantothenate and mycobactin. Using genetic tools, we have
developed for M. tuberculosis, we hypothesize M. leprae can be stably transformed with phage-
based integration proficient plasmids. We plan to incorporate a Bioluminescent Resonance
Energy Transfer (BRET)-Nanoluc and Near infra-red proteins into the plasmid to detect
transformants. Furthermore, we hypothesize that the transformation of M. leprae with the missing
methionine and pantothenate biosynthetic genes and the mycobactin transporters will enable M.
leprae to grow on artificial media. An M. leprae strain that glows would enhance drug
development and the ability to assess the immunological mechanisms that control M. leprae
infections. The genetic engineering of M. leprae to grow on artificial media would enhance our
understanding of evolutionary processes that lead to obligate intracellular parasitism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nanoluciferase reporter phage for rapid phenotypic characterization of resistance to next-generation antimycobacterial agents
-
批准号:10593796
-
项目类别:
-
资助金额:$24.17万
-
财政年份:2023
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
Genetic engineering of Mycobacterium leprae to Glow and Grow
-
批准号:10625474
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2022
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
TB Phage therapy: Optimizing delivery methods of mycobacteriophages to target intracellular Mycobacterium tuberculosis
-
批准号:10312824
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2020
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis
-
批准号:10237245
-
项目类别:
-
资助金额:$57.21万
-
财政年份:2017
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis
-
批准号:10556037
-
项目类别:
-
资助金额:$76.45万
-
财政年份:2017
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis
-
批准号:9754771
-
项目类别:
-
资助金额:$57.21万
-
财政年份:2017
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis
-
批准号:9417850
-
项目类别:
-
资助金额:$56.19万
-
财政年份:2017
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
Drugs targeting persistent Mycobacterium Tuberculosis
-
批准号:8439505
-
项目类别:
-
资助金额:$68.99万
-
财政年份:2013
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
Drugs targeting persistent Mycobacterium Tuberculosis
-
批准号:8822803
-
项目类别:
-
资助金额:$38.64万
-
财政年份:2013
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
Drugs targeting persistent Mycobacterium Tuberculosis
-
批准号:9039521
-
项目类别:
-
资助金额:$63.15万
-
财政年份:2013
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
Drugs targeting persistent Mycobacterium Tuberculosis
-
批准号:8641310
-
项目类别:
-
资助金额:$66.57万
-
财政年份:2013
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
Drugs targeting persistent Mycobacterium Tuberculosis
-
批准号:9132464
-
项目类别:
-
资助金额:$25.98万
-
财政年份:2013
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
"Genetic Approaches for Improving Tuberculosis Vaccines"
-
批准号:8511539
-
项目类别:
-
资助金额:$41.63万
-
财政年份:2013
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
Reporter Phages for Diagnosis of Drug-Resistant TB in HIV High-Burden Populations
-
批准号:8697724
-
项目类别:
-
资助金额:$51.41万
-
财政年份:2013
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
Vaccines for Extensively Drug Resistant Tuberculosis
-
批准号:8269514
-
项目类别:
-
资助金额:$142.77万
-
财政年份:2012
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
Vaccines for Extensively Drug Resistant Tuberculosis
-
批准号:8462534
-
项目类别:
-
资助金额:$104.52万
-
财政年份:2012
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
Vaccines for Extensively Drug Resistant Tuberculosis
-
批准号:8653531
-
项目类别:
-
资助金额:$111.19万
-
财政年份:2012
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
Program/Project Administrative
-
批准号:8049859
-
项目类别:
-
资助金额:$20.29万
-
财政年份:2011
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
"Genetic Approaches for Improving Tuberculosis Vaccines"
-
批准号:8049832
-
项目类别:
-
资助金额:$38.07万
-
财政年份:2011
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
High throughput Genetic Analysis of Mycobacterium tuberculosis
-
批准号:8047667
-
项目类别:
-
资助金额:$399.41万
-
财政年份:2010
-
负责人:WILLIAM Robert JACOBS
-
依托单位:
海外基金